Kali Inc Acquires Patented Cannabis Extraction Operation Entering $50 Billion Pharma Mrkt and $8 Billion Concentrates Mrkt
November 15 2018 - 8:45AM
InvestorsHub NewsWire
Kali Inc Acquires Patented Cannabis
Extraction Operation Entering $50 Billion Pharma Mrkt and $8
Billion Concentrates Mrkt
Sarasota, FL -- November 15, 2018 --
InvestorsHub NewsWire -- Kali, Inc. (USOTC:
KALY) today announced finalizing the acquisition of NCM
Biotech. NCM Biotech is the developer and owner of a patented
cannabis extraction process - U.S. Patent No. 9,199,960 entitled
“METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS
INCLUDING THE CANNABIS PLANT.” The cannabis pharmaceuticals
market is forecasted to reach $50 billion in sales by 2029.
The cannabis concentrates for wellness, edibles and
recreational markets is forecasted to reach $8.5 billion in annual sales by
2022.
Ongoing NCM Biotech
Pharmaceutical Research That Comes With
Acquisition
NCM Biotech’s current research and
ongoing pharmaceutical developments come with the
acquisition. Commenting on the research NCM Biotech has
undertaken with notable medical institutions in the North East,
Frederick Ferri, CEO and Founder of NCM Biotech said, “Some
feedback has specifically indicated that a number of our candidate
pharmaceutical products under development have a greater efficacy
potential than GW Pharmaceutical [GWPH]
products and candidate products. “
NCM
Biotech’s medical advisory team includes John N.
Gaitanis, MD., Director of Child Neurology at Tufts Medical
Center/Floating Hospital for Children; Lloyd R. Saberski,
M.D., Associate Professor of Anesthesiology and Chronic Pain
Management, Yale University, and John McMichael, Ph.D., President
& CEO Beech Tree Labs.
NCM Biotech Proven Extract
Efficacy For Health and Wellness Product
Infusion
NCM Biotech’s concentrates have been
proven in the health and wellness sector through Puration, Inc.’s
(USOTC:
PURA) licensing of the NCM Biotech patented extraction
process. Puration produces EVERx CBD Sports Water for the
sports nutrition market and recently reported revenue approaching
$1 million in annual sales.
NCM Biotech Major
Pharmaceutical Company Partnerships
Kali, with its recent acquisition of
NCM Biotech, has separately announced entering into a joint venture
(JV) company called US Cannabis Health with Puration and Nouveau
life Pharmaceuticals (USOTC:
NOUV). The purpose of the JV is to combine the respective
contributions of the three companies, and together, to partner
through the JV with major pharmaceutical companies for the purpose
of integrating the three companies’ respective cannabis specialties
with the technologies of the major pharmaceutical
companies.
No Kali Inc Public Holding
Company Reverse or Forward Spilt
Kali Inc. has already made
substantial progress toward resolving the public holding company’s
current reporting delinquency and anticipates having its financial
reporting current within the next 30 days. Kali does not plan
to change the capital structure of the public holding
company. No reverse or forward spit is planned. Kali
plans to promptly divest of its legacy marine management
operation. Existing management plans to exit with the
divestiture and incoming NCM management is slated for senior
management in the Kali public holding company.
Kali plans to release an online
presentation next week to present more details on the structure of
the acquisition announced today and the company’s business
development plans for the acquisition. The shareholder
presentation will be published from a new company website.
Look for new company contact information to come with the launch of
the new company website.
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
CONTACT:
Kali, Inc.
941.444.6994
management@wavemarineservices.com
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024